These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 15049707

  • 1. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
    Hoare SR, Sullivan SK, Schwarz DA, Ling N, Vale WW, Crowe PD, Grigoriadis DE.
    Biochemistry; 2004 Apr 06; 43(13):3996-4011. PubMed ID: 15049707
    [Abstract] [Full Text] [Related]

  • 2. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
    Hoare SR, Sullivan SK, Fan J, Khongsaly K, Grigoriadis DE.
    Peptides; 2005 Mar 06; 26(3):457-70. PubMed ID: 15652653
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding.
    Gkountelias K, Tselios T, Venihaki M, Deraos G, Lazaridis I, Rassouli O, Gravanis A, Liapakis G.
    Mol Pharmacol; 2009 Apr 06; 75(4):793-800. PubMed ID: 19124613
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Photoaffinity cross-linking of the corticotropin-releasing factor receptor type 1 with photoreactive urocortin analogues.
    Kraetke O, Holeran B, Berger H, Escher E, Bienert M, Beyermann M.
    Biochemistry; 2005 Nov 29; 44(47):15569-77. PubMed ID: 16300406
    [Abstract] [Full Text] [Related]

  • 10. Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain.
    Beyermann M, Heinrich N, Fechner K, Furkert J, Zhang W, Kraetke O, Bienert M, Berger H.
    Br J Pharmacol; 2007 Jul 29; 151(6):851-9. PubMed ID: 17533422
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of corticotropin-releasing factor type I receptor regulation by nonpeptide antagonists.
    Hoare SR, Sullivan SK, Ling N, Crowe PD, Grigoriadis DE.
    Mol Pharmacol; 2003 Mar 29; 63(3):751-65. PubMed ID: 12606786
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Localization of agonist- and antagonist-binding domains of human corticotropin-releasing factor receptors.
    Liaw CW, Grigoriadis DE, Lorang MT, De Souza EB, Maki RA.
    Mol Endocrinol; 1997 Dec 29; 11(13):2048-53. PubMed ID: 9415408
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The three-dimensional structure of the N-terminal domain of corticotropin-releasing factor receptors: sushi domains and the B1 family of G protein-coupled receptors.
    Perrin MH, Grace CR, Riek R, Vale WW.
    Ann N Y Acad Sci; 2006 Jul 29; 1070():105-19. PubMed ID: 16888152
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors.
    Hoare SR.
    Drug Discov Today; 2005 Mar 15; 10(6):417-27. PubMed ID: 15808821
    [Abstract] [Full Text] [Related]

  • 17. An aspartate residue at the extracellular boundary of TMII and an arginine residue in TMVII of the gastrin-releasing peptide receptor interact to facilitate heterotrimeric G protein coupling.
    Donohue PJ, Sainz E, Akeson M, Kroog GS, Mantey SA, Battey JF, Jensen RT, Northup JK.
    Biochemistry; 1999 Jul 20; 38(29):9366-72. PubMed ID: 10413511
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences.
    Dautzenberg FM, Py-Lang G, Higelin J, Fischer C, Wright MB, Huber G.
    J Pharmacol Exp Ther; 2001 Jan 20; 296(1):113-20. PubMed ID: 11123370
    [Abstract] [Full Text] [Related]

  • 20. The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin.
    Perrin MH, Sutton S, Bain DL, Berggren WT, Vale WW.
    Endocrinology; 1998 Feb 20; 139(2):566-70. PubMed ID: 9449626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.